Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Evommune (EVMN) Return on Sales (2024 - 2025)

Evommune (EVMN) has disclosed Return on Sales for 2 consecutive years, with 7.75% as the latest value for Q4 2025.

  • Quarterly Return on Sales changed N/A to 7.75% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 7.75% through Dec 2025, changed N/A year-over-year, with the annual reading at 5.98% for FY2025, 356.0% up from the prior year.
  • Return on Sales for Q4 2025 was 7.75% at Evommune, down from 1.25% in the prior quarter.
  • The five-year high for Return on Sales was 936.24% in Q3 2024, with the low at 7.75% in Q4 2025.